Log In Sign up
The largest database of trusted experimental protocols

Igg2a

Manufactured by Genentech
Visit Supplier

The IgG2a is a type of immunoglobulin G antibody used in laboratory research. It is a key component in various immunoassays and cell biology applications.

Automatically generated - may contain errors

Lab products found in correlation

Boyden chamber, by Merck Group (1 mentions) Rmtnf α, by Thermo Fisher Scientific (1 mentions) Rhil 22, by R&D Systems (1 mentions)

2 protocols using igg2a

1

Anti-CD20 Therapy in PA Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
PA mice were intravenously treated every 3 weeks for 18 weeks with 250 μg of anti-CD20 [33 ] or isotype control (IC) Ab (IgG2a) (Genentech Inc.). PA donors were not re-challenged prior to sacrifice for transplant. NA recipients were irradiated, reconstituted, and challenged (as described above).
Moutsoglou D.M, & Dreskin S.C. (2016). B cells establish, but do not maintain, long-lived murine anti-peanut IgE. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 46(4), 640-653.
+ Open protocol
+ Expand
2

Neutralizing Antibodies in IL-22 Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
IL-22 neutralizing antibodies and IgG2a control were provided by Genentech (San Francisco, CA). rmIL-22 and rmTNF-α were from Peprotech (London, UK), rmIL-1a and rhIL-22 from R&D Systems (Minneapolis, MN), ELISA kits from Peprotech, R&D or Antigenix America and Boyden chambers from Millipore (Billerica, MA).
Giannou A.D., Kempski J., Shiri A.M., Lücke J., Zhang T., Zhao L., Zazara D.E., Cortesi F., Riecken K., Amezcua Vesely M.C., Low J.S., Xu H., Kaffe E., Garcia-Perez L., Agalioti T., Yamada Y., Jungraithmayr W., Zigmond E., Karstens K.F., Steglich B., Wagner J., Konczalla L., Carambia A., Schulze K., von Felden J., May P., Briukhovetska D., Bedke T., Brockmann L., Starzonek S., Lange T., Koch C., Riethdorf S., Pelczar P., Böttcher M., Sabihi M., Huber F.J., Reeh M., Grass J.K., Wahib R., Seese H., Stüben B.O., Fard-Aghaie M., Duprée A., Scognamiglio P., Plitzko G., Meiners J., Soukou S., Wittek A., Manthey C., Maroulis I.C., Arck P.C., Perez D., Gao B., Zarogiannis S.G., Strowig T., Pasqualini R., Arap W., Gosálvez J.S., Kobold S., Prinz I., Guse A.H., Tachezy M., Ghadban T., Heumann A., Li J., Melling N., Mann O., Izbicki J.R., Pantel K., Schumacher U., Lohse A.W., Flavell R.A., Gagliani N, & Huber S. (2023). Tissue resident iNKT17 cells facilitate cancer cell extravasation in liver metastasis via interleukin-22. Immunity, 56(1), 125-142.e12.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!